{"id":3249,"date":"2012-10-04T06:30:00","date_gmt":"2012-10-04T06:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\/"},"modified":"2012-10-04T06:30:00","modified_gmt":"2012-10-04T06:30:00","slug":"shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\/","title":{"rendered":"Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012"},"content":{"rendered":"<p><span>Xvivo Perfusion AB was spun off from Vitrolife AB on October 1, whereby Vitrolife shareholders received one share in Xvivo Perfusion for each share in Vitrolife. Xvivo Perfusion shares have been approved for trade on NASDAQ OMX First North and the first day for trade will be October 8. <\/span><\/p>\n<p><span>In view of the listing on First North, Xvivo Perfusion is today publishing a company description that is available on the company\u2019s website.<\/span><\/p>\n<p><span>October 4, 2012<br \/>Gothenburg<br \/>Xvivo Perfusion AB (publ)<br \/>Magnus Nilsson<br \/>CEO<\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><strong>For further information, please contact:<br \/><\/strong>Magnus Nilsson, CEO or Christoffer Rosenblad, CFO Xvivo Perfusion AB<\/span><br \/><span>Tel: +46 31 788 21 50 (switchboard) or +46 31 788 21 59 (Christoffer direct)<\/span><\/p>\n<p><span>The information was submitted for publication on October 4, 2012 at 8:30 a.m.<\/span><\/p>\n<p><span>This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/p>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Xvivo Perfusion AB was spun off from Vitrolife AB on October 1, whereby Vitrolife shareholders received one share in Xvivo&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-3249","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-ci"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012 - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012 - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Xvivo Perfusion AB was spun off from Vitrolife AB on October 1, whereby Vitrolife shareholders received one share in Xvivo...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\\\/\",\"name\":\"Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012 - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2012-10-04T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012 - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\/","og_locale":"en_US","og_type":"article","og_title":"Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012 - XVIVO","og_description":"Xvivo Perfusion AB was spun off from Vitrolife AB on October 1, whereby Vitrolife shareholders received one share in Xvivo...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\/","name":"Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012 - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2012-10-04T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/shares-in-xvivo-perfusion-ab-will-begin-trading-on-nasdaq-omx-first-north-on-october-8-2012\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}